Recommendations of the Second Panel on Cost Effectiveness in Health and Medicine: A Reference, Not a Rule Book

• Published in: American journal of preventive medicine 2018-04, Vol.54 (4), p.600-602
• Main Authors: Carias, Cristina, Chesson, Harrell W., Grosse, Scott D., Li, Rui, Meltzer, Martin I., Miller, Gabrielle F., Murphy, Louise B., Nurmagambetov, Tursynbek A., Pike, Jamison J., Whitham, Hilary K.
• Format: Article
• Language: English
• Subjects: Cost benefit analysis; Cost-Benefit Analysis - methods; Cost-Benefit Analysis - standards; Decision makers; Guidelines as Topic; Health care expenditures; Health care policy; Health Services Research - methods; Health Services Research - standards; Health status; Humans; Impact analysis; Quality-Adjusted Life Years; United States
• ISSN: 0749-3797; 1873-2607
• DOI: 10.1016/j.amepre.2017.11.013

Cost-effectiveness analysis (CEA), as noted by the Second Panel on Cost Effectiveness in Health and Medicine, "provides a framework for comparing the relative value of different interventions, along with information that can help decision makers sort through alternatives and decide which ones best serve their programmatic and financial needs." The CEA, as well as other methods of economic evaluation, such as budgetary impact analysis and cost-benefit analysis, can inform health policy decisions. In 1996, the first Panel on Cost Effectiveness in Health and Medicine issued recommendations intended to improve the quality and comparability of CEA studies. The Second Panel has provided updated recommendations on the conduct, documentation, and reporting of CEAs with the same general intent. Notably, the Second Panel recommends inclusion of an impact inventory, which is a checklist of health and non-health outcomes and costs to be considered in CEAs.